Search - tctmd.com

Displaying 641 - 660 of 1277

Sort: Relevancy | Date

News Daily News

Revisión Anual: Los Médicos Debaten las Noticias Intervencionistas Más Importantes de 2013

Yael L. Maxwell

January 27, 2014

Presentation ISET 2014

A Randomized Multicenter Clinical Trial of the Role of Renal Artery Stenting in Preventing Cardiovascular and Renal Endpoints: Results of the CORAL Study

Presenter: Christopher J. Cooper

January 20, 2014

News Industry News

Covidien to Exit OneShot™ Renal Denervation Program

January 20, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Daily News

Se Publican los Nuevos Indicadores de Rendimiento de PCI para la Mejora de la Calidad de la Atención Sanitaria

January 06, 2014

News Daily News

New PCI Performance Measures Issued to Improve Quality of Care

January 06, 2014

News Daily News

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Jason Kahn

January 01, 2014

News Daily News

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Jason Kahn

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY：达比加群在不同肾功能患者中安全、有效

Yael L. Maxwell

December 30, 2013

News Daily News

EVAR Reduces Short-, Long-term Mortality vs. Surgery for Ruptured AAA

December 30, 2013

News Daily News

Comparada con la Cirugía, EVAR Reduce la Mortalidad a Corto y Largo Plazo en el Manejo de Roturas de AAA

December 30, 2013

Presentation

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Presenter: Ziad Hijazi

December 23, 2013

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

Advertisement

Revisión Anual: Los Médicos Debaten las Noticias Intervencionistas Más Importantes de 2013

A Randomized Multicenter Clinical Trial of the Role of Renal Artery Stenting in Preventing Cardiovascular and Renal Endpoints: Results of the CORAL Study

Covidien to Exit OneShot™ Renal Denervation Program

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Se Publican los Nuevos Indicadores de Rendimiento de PCI para la Mejora de la Calidad de la Atención Sanitaria

New PCI Performance Measures Issued to Improve Quality of Care

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY：达比加群在不同肾功能患者中安全、有效

EVAR Reduces Short-, Long-term Mortality vs. Surgery for Ruptured AAA

Comparada con la Cirugía, EVAR Reduce la Mortalidad a Corto y Largo Plazo en el Manejo de Roturas de AAA

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content